Winter EM - Search Results

1

Duration of Bisphosphonate Drug Holidays in Osteoporosis Patients: A Narrative Review of the Evidence and Considerations for Decision-Making.

Hayes KN, Winter EM, Cadarette SM, Burden AM. Hayes KN, et al. Among authors: winter em. J Clin Med. 2021 Mar 9;10(5):1140. doi: 10.3390/jcm10051140. J Clin Med. 2021. PMID: 33803095 Free PMC article. Review.

2

Osteoporosis Treatment with Anti-Sclerostin Antibodies-Mechanisms of Action and Clinical Application.

Rauner M, Taipaleenmäki H, Tsourdi E, Winter EM. Rauner M, et al. Among authors: winter em. J Clin Med. 2021 Feb 16;10(4):787. doi: 10.3390/jcm10040787. J Clin Med. 2021. PMID: 33669283 Free PMC article. Review.

3

Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS).

Vestergaard Kvist A, Faruque J, Vallejo-Yagüe E, Weiler S, Winter EM, Burden AM. Vestergaard Kvist A, et al. Among authors: winter em. J Clin Med. 2021 Apr 13;10(8):1660. doi: 10.3390/jcm10081660. J Clin Med. 2021. PMID: 33924496 Free PMC article.

4

When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.

Hayes KN, Baschant U, Hauser B, Burden AM, Winter EM. Hayes KN, et al. Among authors: winter em. Front Endocrinol (Lausanne). 2021 Dec 15;12:782118. doi: 10.3389/fendo.2021.782118. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34975756 Free PMC article. Review.

5

Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.

Hayes KN, Baschant U, Hauser B, Burden AM, Winter EM. Hayes KN, et al. Among authors: winter em. Front Endocrinol (Lausanne). 2022 Mar 14;13:877512. doi: 10.3389/fendo.2022.877512. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35370960 Free PMC article.

6

Determinants of Quality of Life in Adult Patients with Chronic Non-Bacterial Osteomyelitis (CNO) of the Sternocostoclavicular Region (SCCH): A Dutch Single Center Study.

Ramautar AIE, Andela CD, Hamdy NAT, Winter EM, Appelman-Dijkstra NM. Ramautar AIE, et al. Among authors: winter em. J Clin Med. 2022 Mar 27;11(7):1852. doi: 10.3390/jcm11071852. J Clin Med. 2022. PMID: 35407460 Free PMC article.

7

Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study.

Hayes KN, Burden AM, Winter EM, Hauser B. Hayes KN, et al. Among authors: winter em. Rheumatol Adv Pract. 2022 Feb 17;6(2):rkac010. doi: 10.1093/rap/rkac010. eCollection 2022. Rheumatol Adv Pract. 2022. PMID: 35531047 Free PMC article. No abstract available.

8

Bone Material Strength Index as Measured by Impact Microindentation is Low in Patients with Primary Hyperparathyroidism.

Schoeb M, Winter EM, Sleddering MA, Lips MA, Schepers A, Snel M, Appelman-Dijkstra NM. Schoeb M, et al. Among authors: winter em. J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2527-e2534. doi: 10.1210/clinem/dgab207. J Clin Endocrinol Metab. 2021. PMID: 33780545 Free PMC article.

9

The effect of osteoporosis treatment on bone mass.

Appelman-Dijkstra NM, Oei HLDW, Vlug AG, Winter EM. Appelman-Dijkstra NM, et al. Among authors: winter em. Best Pract Res Clin Endocrinol Metab. 2022 Mar;36(2):101623. doi: 10.1016/j.beem.2022.101623. Epub 2022 Feb 9. Best Pract Res Clin Endocrinol Metab. 2022. PMID: 35219602 Free article. Review.

10

Parathyroid Hormone-Related Protein-Induced Hypercalcemia of Pregnancy Successfully Reversed by a Dopamine Agonist.

Winter EM, Appelman-Dijkstra NM. Winter EM, et al. J Clin Endocrinol Metab. 2017 Dec 1;102(12):4417-4420. doi: 10.1210/jc.2017-01617. J Clin Endocrinol Metab. 2017. PMID: 29053801

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page